Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.
O'Brien S; Rizzieri DA; Vey N; Ravandi F; Krug UO; Sekeres MA; Dennis M; Venditti A; Berry DA; Jacobsen TF; Staudacher K; Bergeland T; Giles FJ; British Journal Of Haematology, 2012, vol. 158, issue 5, p 581, ISSN 13652141. ISBN 13652141.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef